Firm
Partner Charlie Henn reveals some key achievements from 2024 and explains how the firm takes advantage of its experience
The Delhi High Court declined to stop Dr. Reddy’s from manufacturing Novo Nordisk’s drug, but will continue to hear the Danish company’s injunction application
A new dispute involving Mondelēz and Aldi, and a copyright ruling related to 'Eleanor’ Ford Mustangs were also among the top talking points this week
Vida Panganiban-Alindogan at SyCip Salazar Hernandez & Gatmaitan discusses IP valuation and why no IP practice area is more important than the other
Sponsored
Sponsored
-
Sponsored by Saint Island International Patent & Law OfficesFrank Liu of Saint Island International Patent & Law Offices describes the progress of a significant patent infringement case in Taiwan and the extended involvement of the Intellectual Property and Commercial Court -
Sponsored by Spoor & FisherIP judgments in Zimbabwe are unusual, says Chris Walters of Spoor & Fisher Jersey. So the recent Supreme Court decision in Cairns Foods v Netrade Marketing is welcome
-
Sponsored by Gün and PartnersSelin Sinem Erciyas of Gün + Partners suggests that intellectual property waivers and compulsory licensing are not the answer in developing and accessing vaccines, and explains why governments should be focused on R&D
-
Sponsored by Wanhuida Intellectual PropertyYue Guan of Wanhuida Intellectual Property analyses a decision by the China National Intellectual Property Administration on the validity of a pulmonary hypertension drug and the implications for pharmaceutical patentees
-
Sponsored by Purplevine IPXiaoyan Zhou of Purplevine IP explains how the introduction of administrative measures for registering, and filing records relating to, medical devices in China should affect companies’ IP strategy
-
Sponsored by CASCAS explains the five high-risk areas of IP for R&D organisations and identifies how companies can protect their innovations and safeguard their growth potential
